JP2023513752A5 - - Google Patents
Info
- Publication number
- JP2023513752A5 JP2023513752A5 JP2022548955A JP2022548955A JP2023513752A5 JP 2023513752 A5 JP2023513752 A5 JP 2023513752A5 JP 2022548955 A JP2022548955 A JP 2022548955A JP 2022548955 A JP2022548955 A JP 2022548955A JP 2023513752 A5 JP2023513752 A5 JP 2023513752A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- cancer
- fragment
- polynucleotide according
- pathway
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20200018169 | 2020-02-14 | ||
| KR10-2020-0018169 | 2020-02-14 | ||
| PCT/KR2021/001904 WO2021162521A1 (ko) | 2020-02-14 | 2021-02-15 | 외부에서 도입된 세포 신호 조절 인자를 과발현하는 면역 세포 및 이들의 용도 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023513752A JP2023513752A (ja) | 2023-04-03 |
| JP2023513752A5 true JP2023513752A5 (https=) | 2024-02-26 |
Family
ID=77291621
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022548955A Pending JP2023513752A (ja) | 2020-02-14 | 2021-02-15 | 外部から導入された細胞シグナル伝達調節因子を過剰発現する免疫細胞及びその使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230212254A1 (https=) |
| EP (1) | EP4105232A4 (https=) |
| JP (1) | JP2023513752A (https=) |
| KR (1) | KR20210103975A (https=) |
| CN (1) | CN115427451B (https=) |
| AU (1) | AU2021219233A1 (https=) |
| TW (1) | TW202146440A (https=) |
| WO (1) | WO2021162521A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4472742A1 (en) * | 2022-02-03 | 2024-12-11 | University College Cardiff Consultants Limited | Novel t-cell receptor |
| CN114774364B (zh) * | 2022-04-26 | 2024-04-26 | 深圳市体内生物医药科技有限公司 | 一种嵌合抗原受体t细胞及其制备方法和应用 |
| WO2024121426A1 (en) * | 2022-12-09 | 2024-06-13 | Cemm - Forschungszentrum Für Molekulare Medizin Gmbh | Method for optimizing t cells for immuno-therapy |
| IL322949A (en) | 2023-03-03 | 2025-10-01 | Arsenal Biosciences Inc | Systems targeting PSMA and CA9 |
| CN116376844B (zh) * | 2023-05-31 | 2023-08-11 | 四川大学华西医院 | 包含shp2 sh2结构域的靶向her2阳性肿瘤的car-t及制备方法和应用 |
| CN116355859B (zh) * | 2023-05-31 | 2023-08-11 | 四川大学华西医院 | 包含shp2 n-sh2结构域的靶向her2阳性肿瘤的car-t及制备方法和应用 |
| CN116814664B (zh) * | 2023-08-25 | 2023-12-12 | 中国医学科学院肿瘤医院 | 一种扩展肿瘤识别表位的cea嵌合抗原受体t细胞的制备与应用 |
| WO2025111277A2 (en) * | 2023-11-20 | 2025-05-30 | Carisma Therapeutics Inc. | Compositions and methods relating to redirected soluble modulators |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002098897A2 (en) | 2001-06-01 | 2002-12-12 | Cornell Research Foundation, Inc. | Modified antibodies to prostate-specific membrane antigen and uses thereof |
| DK2956175T3 (da) * | 2013-02-15 | 2017-11-27 | Univ California | Kimærisk antigenreceptor og fremgangsmåder til anvendelse deraf |
| SI3597742T1 (sl) * | 2014-10-09 | 2022-11-30 | Yamaguchi University | CAR ekspresijski vektor in T celice, ki izražajo CAR |
| CN109863242A (zh) * | 2016-08-30 | 2019-06-07 | 纪念斯隆-凯特林癌症中心 | 用于治疗病毒感染和其它感染的免疫细胞组合物和使用方法 |
| MA46862A (fr) * | 2016-11-17 | 2019-09-25 | Bluebird Bio Inc | Convertisseur de signaux tgf béta |
| GB201620070D0 (en) * | 2016-11-28 | 2017-01-11 | Autolus Ltd | Signal transduction modifying protein |
| SG11201906552WA (en) * | 2017-01-25 | 2019-08-27 | Tessa Therapeutics Pte Ltd | TGF-ß DECOY RECEPTOR |
| US20190381171A1 (en) * | 2017-02-17 | 2019-12-19 | Unum Therapeutics Inc. | Co-use of anti-bcma antibody and antibody-coupled t cell receptor (actr) in cancer therapy and b cell disorders |
| KR102746901B1 (ko) * | 2017-03-03 | 2024-12-26 | 옵시디안 테라퓨틱스, 인크. | Cd19 조성물 및 면역요법을 위한 방법 |
| CN110831619A (zh) * | 2017-03-22 | 2020-02-21 | 诺华股份有限公司 | 具有增强功效的生物标志和car t细胞疗法 |
| CA3287539A1 (en) * | 2017-06-21 | 2026-03-02 | Icell Gene Therapeutics Llc | CHIMERIC ANTIGEN RECEPTORS (CARs), COMPOSITIONS AND METHODS THEREOF |
| CN108218999B (zh) * | 2018-01-02 | 2021-06-11 | 广东省人民医院(广东省医学科学院) | 分泌il-7的嵌合抗原受体、病毒载体、表达细胞及制备方法与药物 |
| CN109265565B (zh) * | 2018-10-10 | 2021-06-01 | 苏州大学 | 一种携带分子开关的抗CD79b嵌合抗原受体及其修饰的免疫细胞和应用 |
| WO2020123947A1 (en) * | 2018-12-14 | 2020-06-18 | Bluebird Bio, Inc. | Dimerizing agent regulated immunoreceptor complexes |
-
2021
- 2021-02-15 WO PCT/KR2021/001904 patent/WO2021162521A1/ko not_active Ceased
- 2021-02-15 CN CN202180028871.2A patent/CN115427451B/zh active Active
- 2021-02-15 US US17/904,221 patent/US20230212254A1/en active Pending
- 2021-02-15 KR KR1020210019765A patent/KR20210103975A/ko active Pending
- 2021-02-15 EP EP21753514.5A patent/EP4105232A4/en active Pending
- 2021-02-15 JP JP2022548955A patent/JP2023513752A/ja active Pending
- 2021-02-15 AU AU2021219233A patent/AU2021219233A1/en active Pending
- 2021-02-17 TW TW110105348A patent/TW202146440A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023513752A5 (https=) | ||
| JP2025028239A5 (https=) | ||
| JP2021094037A5 (https=) | ||
| JP2020517295A5 (https=) | ||
| JP2018525033A5 (https=) | ||
| JP2021501570A5 (https=) | ||
| RU2018135819A (ru) | Иммунные эффекторные клетки с отредактированным геномом | |
| JP2021519580A5 (https=) | ||
| JP2021087455A5 (https=) | ||
| JP2023123502A5 (https=) | ||
| HRP20231542T1 (hr) | Kimerni antigenski receptori koji ciljaju bcma i postupci njihove uporabe | |
| JP2021519301A5 (https=) | ||
| JP2019535275A5 (https=) | ||
| CN111234033B (zh) | 多链嵌合抗原受体及其用途 | |
| JP2019527557A5 (https=) | ||
| JP2022513460A5 (https=) | ||
| EP4148125A1 (en) | Engineered immune cell for allotransplantation | |
| FI3334765T3 (fi) | Yksidomeenivasta-aineisiin perustuvia kimeerisiä antigeenireseptoreita ja menetelmiä niiden käyttämiseksi | |
| JP2024534471A5 (https=) | ||
| JP2021519072A5 (https=) | ||
| CN114015656A (zh) | 用于同种异体移植的工程化免疫细胞 | |
| JP2024534417A5 (https=) | ||
| JP2023522038A5 (https=) | ||
| JP2021532742A5 (https=) | ||
| EP4194472A1 (en) | Chimeric antigen receptor comprising novel co-stimulatory domain and use thereof |